Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers 14, 6, 1478
- Schlagwort
-
-
- Ereignis
-
Veröffentlichung
- (wo)
-
Greifswald
- (wer)
-
Universität Greifswald
- (wann)
-
2022
- Urheber
-
Siebenhüner, Alexander R.
Langheinrich, Melanie
Friemel, Juliane
Schaefer, Niklaus
Eshmuminov, Dilmurodjon
Lehmann, Kuno
- Beteiligte Personen und Organisationen
-
Wong, David
- DOI
-
10.3390/cancers14061478
- URN
-
urn:nbn:de:gbv:9-opus-61208
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Siebenhüner, Alexander R.
- Langheinrich, Melanie
- Friemel, Juliane
- Schaefer, Niklaus
- Eshmuminov, Dilmurodjon
- Lehmann, Kuno
- Wong, David
- Universität Greifswald
Entstanden
- 2022
Ähnliche Objekte (12)
Pancreatic neuroendocrine tumor mouse models
Single center experience in pancreatic neuroendocrine tumors
Systemic therapy for metastatic pancreatic cancer
Dissecting the signalling network in pancreatic neuroendocrine neoplasms
Target identification and probe development for pancreatic neuroendocrine tumors
When should lymphadenectomy be performed in non-metastatic pancreatic neuroendocrine tumors? A population-based analysis of the German Clinical Cancer Registry Group
New Advances in the Treatment of Metastatic Pancreatic Cancer
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
C-reactive protein (CRP) promotes proliferation and metastasis in pancreatic neuroendocrine neoplasms
Resection of non-functional pancreatic neuroendocrine neoplasms - a single-center retrospective outcome analysis
Pancreatic neuroendocrine tumor mouse models
Single center experience in pancreatic neuroendocrine tumors
Systemic therapy for metastatic pancreatic cancer
Dissecting the signalling network in pancreatic neuroendocrine neoplasms
Target identification and probe development for pancreatic neuroendocrine tumors
When should lymphadenectomy be performed in non-metastatic pancreatic neuroendocrine tumors? A population-based analysis of the German Clinical Cancer Registry Group
New Advances in the Treatment of Metastatic Pancreatic Cancer
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
C-reactive protein (CRP) promotes proliferation and metastasis in pancreatic neuroendocrine neoplasms
Resection of non-functional pancreatic neuroendocrine neoplasms - a single-center retrospective outcome analysis
Pancreatic neuroendocrine tumor mouse models
Single center experience in pancreatic neuroendocrine tumors
Systemic therapy for metastatic pancreatic cancer
Dissecting the signalling network in pancreatic neuroendocrine neoplasms
Target identification and probe development for pancreatic neuroendocrine tumors
When should lymphadenectomy be performed in non-metastatic pancreatic neuroendocrine tumors? A population-based analysis of the German Clinical Cancer Registry Group
New Advances in the Treatment of Metastatic Pancreatic Cancer
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Metastasized pancreatic neuroendocrine tumor in a teenage girl: a case report
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
C-reactive protein (CRP) promotes proliferation and metastasis in pancreatic neuroendocrine neoplasms